Signaturefd, LLC Agenus Inc Transaction History

Signaturefd, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$0.63 - $1.14 $8,135 - $14,720	-12,913 Reduced 69.99%	5,538 $4,000
Q3 2023 Nov 03, 2023	BUY	$1.12 - $1.88 $10,819 - $18,160	9,660 Added 109.89%	18,451 $20,000
Q2 2023 Aug 01, 2023	BUY	$1.31 - $2.04 $6,350 - $9,889	4,848 Added 122.95%	8,791 $14,000
Q1 2023 Apr 28, 2023	BUY	$1.45 - $2.95 $5,717 - $11,631	3,943 New	3,943 $5,000
Q1 2022 May 02, 2022	SELL	$2.35 - $3.47 $446 - $659	-190 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$2.92 - $5.74 $554 - $1,090	190 New	190 $1,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.